2007 resolutions from Dr Ralph Ballard

[Guest guest]

2007 resolutions: Dr Ralph Ballard: Medical Director:

Hope Clinic will offer new options for patients needing treatment.

DIY:

We realize that some patients are not well enough to travel to Melbourne for

initial treatment and

so we will offer many of our treatments for at home 'Do it yourself: DIY'

treatment if your local

health practitioner is prepared to over see the treatment and monitor the

results in consultation

with Dr Ralph Ballard our medical director.

The cost of this treatment will be the cost of the equipment and medication.

Most equipment can be installed by the patient but if you are concerned

about this we can send a

staff member to help you install the equipment.

Single Day Visit to the Hope Clinic for Instruction and Collection of

Equipment:

Patients will be able to spend a day with the staff at the Hope Clinic

experiencing many of the

eight different therapies at the clinic.

Patients will be instructed in the installation and operation of equipment

suitable for treatment of

their medical problem at home.

Patients will collect their equipment and proceed home with enough equipment

and medication

for three months treatment at home. Cost of equipment will depend on the

items required to treat

the individual's medical problems.

We will monitor progress on a monthly basis from blood tests and signs and

symptoms and on a

three monthly basis with scans. Monitoring will be done in co-operation with

your local doctor.

One Week of Treatment at The Hope Clinic, Instruction and Collection of

Equipment:

For those patients who cannot afford the time and/or expense of the three

weeks of treatment this

is an excellent option.

We will monitor progress on a monthly basis from blood tests and signs and

symptoms and on a

three monthly basis with scans. Monitoring will be done in co-operation with

your local doctor.

Three Weeks of Treatment at The Hope Clinic, Instruction and Collection of

Equipment:

This the ideal period for our eight different therapies to take effect and

prepare you for home

therapy.

We will monitor progress on a monthly basis from blood tests and signs and

symptoms and on a

three monthly basis with scans. Monitoring will be done in co-operation with

your local doctor.

Telephone Noel on 0412 994 001 to discuss these options and a

starting time.

Dr Sam Queen: Pathology analysis through ARL with a 105 page report:

We are offering an optional new approach to evaluating the patients' body

chemistry and detoxification.

Optional pathology tests evaluate 81 different chemistries in the body and

these results are

passed through a computer program producing a 100 page report.

We are then able to advise you on how to correct the imbalances within you

body and build a

stronger defence against your medical problems.

The cost of the tests are approximately $430 payable to the pathology

laboratory, and a $150 fee to produce the report from software developed by

Dr Sam Queen.

The body deals with toxins in a very ordered fashion:

* Protective barriers and secretions (skin, mucus, tears, saliva)

* Immunological (inflammation, immunoglobulin response)

* Biotransformation (activation of cytochrome P450 enzyme detoxification

systems)

* Raising blood lipids (HDL, LDL and VLDL cholesterol and

tryglycerides.)24,25

By doing a comprehensive blood chemistry, based on the principles of Free

Radical

Therapy,26 we can gain a fairly accurate idea of which toxin or combination

of toxins we

are dealing with, where the toxin is located, how much is there and how it

is being

transported, and thereby gain some idea of how best to neutralize the toxins

and get them

out.

The protocol we use to help the patient get rid of mercury is a multi-step

process. The

first step involves changing the diet to enhance the body's ability to

handle contaminant

materials. The next step adds specific supplementation and chelation

therapy. We then do

a comprehensive survey of the mouth to determine the best order for removal

of

amalgams and the most compatible type of dental material with which to

replace them.

Only then do we proceed with the removal of amalgam fillings.

Upon examining Nervanne's blood results the following findings were of

particular

interest: her total serum cholesterol was very low at 150 mg/dl with

HDL-cholesterol at

48 mg/dl; and her total protein and albumin levels were low, the globulin

was high

normal.

Nervanne's total cholesterol, HDL-cholesterol and total protein levels had

never before

been this low. So I asked her what sort of dietary regimen she had been

following.

Nervanne had not eaten eggs, red meat or dairy products (except skim milk or

soy milk

on her cereal) for several years prior to her devastating decline in health.

She had reduced

her diet to salads, pasta, fruits, an occasional serving of skinless chicken

and frequent

canned tuna due to convenience and her desire to increase her omega-3

intake. She

regularly consumed " cholesterol-free " crackers with margarine and " lite "

cheese as a

snack. She also consumed many other sources of trans fatty acids--margarine,

pastries,

breads, cereals and chocolate.

Did Nervanne's health fail as a result of her new eating habits, or was it

mere coincidence

that her recent health decline followed the adoption of an extremely

low-fat, lowcholesterol,

low-animal-protein diet? I believe it was the latter and the scientific

literature

confirms my beliefs.

Nervanne's reduction in cholesterol and total serum protein had made her

vulnerable to

bacterial and viral infection by promoting T-cell suppression. This is

especially so in the

presence of mercury, which has been shown to reduce resistance to viruses,

cancer and

autoimmune disease.27,28 Low levels of cholesterol also make T-cell

proliferation more

difficult,29,30,31,32 and the excretion of mercury nearly impossible.

The onset of emotional depression and irritability is frequently reported in

people who

suddenly lower their cholesterol levels. These symptoms have occurred in all

of the

longer-term studies on cholesterol lowering, but rarely do physicians link

their patients'

depressive symptoms with the sudden change in diet or cholesterol level.

Neurotoxins are transported throughout the body attached to protein

components of

lipoproteins, and therefore require cholesterol for their transport and

elimination. These

neurotoxins also have a strong affinity for lipoidal tissue of the nervous

system and brain.

A rise in cholesterol levels and triglycerides in response to neurotoxins

protects by

preventing permanent attachment of the neurotoxin to the nerve and brain

cells.

Symptoms of neurotoxicity are most likely to occur when the cholesterol is

lowered

suddenly or when the affected patient goes on a low-fat, low-cholesterol,

low-protein

diet.

In a human trial, a high-protein, low-carbohydrate diet was compared to a

low-protein,

high-carbohydrate diet. The researchers found greater clearance of toxins

with the highprotein,

low-carbohydrate diet and diminished clearance when the ratio was

reversed.33,34

To utilise the protein correctly, the fat on the " lamb " needs to be eaten.

The use of

additional butter or lard in cooking is of paramount importance. By having

adequate fat,

bile production is stimulated, absorption of minerals increased and the

excretion of

mercury facilitated as long as constipation is avoided.

In my practice, I have found that people who are sturdy in structure recover

more quickly

and have less reactivity during their treatment, compared with people who

are extremely

thin or who lose the most weight or undergo ill-advised fasting procedures

concurrently

while having been exposed to toxins such as mercury.35 This observation is

supported by

recent studies published in the Journal of Obesity.36

A correct cholesterol response is fundamental to move mercury and other

neurotoxins to

sites where they can be excreted. A Danish study of 50,318 users of statin

(cholesterol lowering)

drugs revealed a higher risk of peripheral neuropathy related to the

percentage

of drop in total cholesterol. In other words, lowering cholesterol increases

risk of

reactivity to nerve toxins37 resulting in pain, paraesthesia, numbness and

demyelinating

effects. Six additional studies since 1994 have indicated the same rise in

poly peripheral

neuropathy symptoms for users of statin drugs,38,39,40,41,42,43 supporting

our clinical

findings that low cholesterol levels in the presence of a potent neurotoxin

such as

mercury found in amalgam fillings or any other source, is a recipe for

disaster.

Nervanne's history was characteristic of this pattern.

Case History: Therapy:

Our treatment for Nervanne involved a radical change in her diet followed by

the careful

removal of her amalgam fillings (as well as her root-filled teeth). Proper

diet is

fundamental to clearing toxins, as well as to regaining the best of health.

We advised

Nervanne to eliminate tuna and other seafood's from her diet, but to

incorporate a variety

of meats, eggs and whole milk dairy products. The only seafood allowed is

cod liver oil

to provide vitamins A and D.

Protein deprivation has been shown to decrease the liver content of several

of the

cytochrome P450 enzymes, the enzyme system the body calls upon to remove

toxins.44

Mercury also blocks the P450 system.45 Trans fats also interfere with the

P450

detoxification enzyme system, according to research carried out by Dr.

Enig, so

these must also be eliminated from the diet.46

The proteins in the diet must be animal proteins, providing a complete

spectrum of amino

acids. A study of Asian vegetarians with incomplete amino acid intake showed

reduced

clearing of xenobiotics.47 Low levels of hydrochloric acid have an adverse

impact on the

availability of dietary amino acids, even in a higher protein diet, so

stimulating the

pancreas using lacto-fermented foods is crucial. Our protocol makes the use

of cultured

dairy products rich in whey protein. Not only will whey provide the complete

protein

needed for metabolization of xenobiotics and mercury, it has also been shown

to increase

glutathione content in the liver.48,49 We recommend sheep's milk yoghurt,

rich in lauric

acid, whey and glutathione.

By April of 2002, Nervanne's migraines had completely ceased and her

gastrointestinal

symptoms had abated. For the first time in many years, she can string a

sentence together

without stuttering. Her inability to cope, internal irritability and

feelings of helplessness

had resolved and she was now able care for her family and support her

husband's

efforts. The children's behaviours were also improving and the parents were

ready to

commence a program for the child with autism.

REFERENCES

1. Queen HL. Chronic Mercury Toxicity: New Hope Against An Endemic Disease,

Queen and Company Health Communications, Inc., Colorado Springs, Colorado,

1998.

2. Renzoni A, Zino F, Franchi E. Mercury Levels Along the Food Chain and

Risk

for Exposed Populations. Environmental Research, 1998;77(2):68-72.

3. Drexler H, Schaller KH. The Mercury Concentration in Breast Milk

Resulting

from Amalgam Fillings and Dietary Habits. Environmental Research,

1998;77(2):124-129.

4. Arenholt-Bindslev D, Larsen, AH. Mercury Levels and Discharge in Waste

Water

from Dental Clinics. Water Air Soil Pollution, 1996;86(1-4):93-9.

5. Leistevuo J, Leistevuo T, Helenius H, Pyy L, Osterblad M, Huovinen P,

Tenovuo

J. Dental amalgam fillings and the amount of organic mercury in human

saliva.

Caries Res May-June 2001;35(3):163-6.

6. Geier MR, Geier DA 2003, Thimerosal in Childhood Vaccines,

Neurodevelopment Disorders, and Heart Disease in the United States. Journal

of

American Physicians and Surgeons, 2003;8(1):6-11.

7. Renzoni, op cit.

8. Heintze U, son S, Derand T, Birkhed D. Methylation of Mercury from

Dental Amalgam and Mercuric Chloride by Oral Streptococci in vitro. Scand.

J.

Dental Research 1983;91(2) 150-152.

9. Harda M. Minamata Disease: Methylmercury Poisoning in Japan Caused by

Environmental Pollution. Crit Rev Toxicol 1995;25(1):1-24.

10. Fukuda Y, Ushijima K, Kitano T, Sakamoto M, Futatsuka M. An Analysis of

Subjective Complaints in a Population Living in a Methylmercury-Polluted

Area.

Environ Res 1999;81(2):100-107.

11. Renzon1, op cit.

12. Vimy MJ, Lorscheider, FL. Intra-Oral Air Mercury Released from Dental

Amalgam. J Den Res 1985;64:1069-71.

13. Vimy MJ and others. Maternal-fetal Distribution of Mercury203 Released

from

Dental Amalgam Fillings. J Am Physiol 1990, R939-45.

14. Vimy MJ, Lorscheider FL. Dental Amalgam Mercury Daily Dose Estimated

from

Intra-oral Vapor Measurements: a Predictor of Mercury Accumulation in Human

Tissues. J Trace Elem Exp Med 1990;3: 111-23.

15. Drasch G, Roider G. Zahnamalgam und Schwanger-schaft. Geburtsh. und

Frauenheilk, 1995;55:M63-M65.

16. Drexler, op cit.

17. Drexler, op cit

18. Mahafey KR, Rice GE. Environmental Protection Agency Office of Air

Quality

Planning and Standards. Mercury Study Report to Congress. Govt Reports

Announcements and Index (GRA and I), Issue 09,1998. Also Dec, 1999.

www.epa.gov/ttnuatw1/112nmerc/mercury.html.

19. World Health Organization, Environmental Health Criteria 118: Inorganic

Mercury, Geneva, 1991.

20. Geier, op cit.

21. Geier, op cit.

22. Salonen JT and others. Circulation 1995;91:645-55.

23. Salonen JT and others. Circulation October 15, 1995;(Suppl)

92(8):abstract 1040.

24. Queen, HL, Cholesterol-Lowering Drugs Should Carry A Warning: The

Mercury

Connection. Heart Talk 7(2): 9-15, November 1988

25. Queen HL, Health Realities Journal, Number 1,Volume 19, 2003.

26. www.healthrealities.org

27. RB. The carcinogenicity of metals in humans. Cancer Causes &

Control

May 1997;8(3): 371-85.

28. Whitekus MJ and others. Protection Against CD95-Mediated Apoptosis By

Inorganic Mercury In Jurkat T Cells. J Immunol June 15, 1999;162(12):

7162-70.

29. Hui DY, Harmony AK. Biochem J, 1980;192:91.

30. M. Science News, November 1988, p.348.

31. Meydani M. Dietary effects on detoxification processes. In: Hathcock JN,

ed.

Nutritional Toxicology Vol. 2. San Diego, CA: Academic Press; 1987;1-40.

32. Brodie MJ, Boobis AR, Toverud EL and others. Drug metabolism in white

vegetarians. Br J Clin Pharmacol 1980;9:523-525.

33. Kappas A, KE, Conney AH, Alvares AP. Influence of dietary

protein

and carbohydrate on antipyrine and theophylline metabolism in man. Clin

Pharmacol Ther 1976;20:643-653.

34. KE, Kappas A. Dietary regulation of cytochrome P450. Annu Rev

Nutr

1991;11:141-167.

35. s J, Juhaeri M, Cai J. Am J Epidemiol May 15,

2001;153(10):946-953.

36. DB and others. Internat J Obesity & Related Metabol Disorders

March

2002;26(3):410-416.

37. Gaist D and others. Statins and risk of polyneuropathy. Neurol May 1,

2002;58:1333-1337.

38. s MB. Ann Intern Med 1994;120:970.

39. Ahmed S. Lovastatin and Peripheral Neuropathy. Am Heart J 1995;130:1321.

40. Phan T and others. Peripheral Neuropathy Associated with Simvastatin. J

Neurol

Neurosurg Psy 1995;58:625-28.

41. Ziajka PE. South Med J 1998;91:667-68.

42. Jeppesen U and others. Eur J Clin Pharmacol 1999;54:835-38.

43. Gaist D and others. Eur J Clin Pharmacol 2001;56:931-33.

44. Meydani M. Dietary effects on detoxification processes. In: Hathcock JN,

ed.

Nutritional Toxicology Vol. 2. San Diego, CA: Academic Press; 1987;1-40.

45. , op cit.

46. Enig MG. Modification of Membrane Lipid Composition and Mixed-Function

Oxidases in Mouse Liver Microsomes by Dietary Trans Fatty Acids. Doctoral

Thesis, University of land, 1984.

47. Brodie MJ, Boobis AR, Toverud EL and others. Drug metabolism in white

vegetarians. Br J Clin Pharmacol 1980;9:523-525.

48. Bounous G, Gervais F, Amer V and others. The influence of dietary whey

protein

on tissue glutathione and the diseases of aging. Clin Invest Med

1989;12:343-349.

49. McIntosh GH, Regester GO, Le Leu RK and others. Dairy proteins protect

against

dimethylhydrazine-induced intestinal cancers in rats. J Nutr

1995;125:809-816.

167 Street Melbourne Australia

P O Box 137 Parkville 3052 Australia

Telephone 03 9639 6090 International 613 9639 6090

Mobile 0412 994 001 International 61 412 994 001

Fax 03 9639 4006 International 613 9639 4006

Web www.smile.org.au

Sapere aude: 'Dare to be wise'

The information transmitted in this document is intended only for the

recipient(s) to which it is addressed and may contain confidential and

privileged material.

Any review, retransmission, dissemination or other use of, or taking any

action in reliance upon, this information by persons or entities other than

the intended recipient is prohibited.

If you receive this in error, please contact the sender and then delete. We

have taken precautions to minimise the risk of transmitting software

viruses, but we advise you to carry out your own virus checks on any

attachment to this message. We cannot accept liability for any loss or

damage caused by software viruses.

[Guest guest]

2007 resolutions: Dr Ralph Ballard: Medical Director:

Hope Clinic will offer new options for patients needing treatment.

DIY:

We realize that some patients are not well enough to travel to Melbourne for

initial treatment and

so we will offer many of our treatments for at home 'Do it yourself: DIY'

treatment if your local

health practitioner is prepared to over see the treatment and monitor the

results in consultation

with Dr Ralph Ballard our medical director.

The cost of this treatment will be the cost of the equipment and medication.

Most equipment can be installed by the patient but if you are concerned

about this we can send a

staff member to help you install the equipment.

Single Day Visit to the Hope Clinic for Instruction and Collection of

Equipment:

Patients will be able to spend a day with the staff at the Hope Clinic

experiencing many of the

eight different therapies at the clinic.

Patients will be instructed in the installation and operation of equipment

suitable for treatment of

their medical problem at home.

Patients will collect their equipment and proceed home with enough equipment

and medication

for three months treatment at home. Cost of equipment will depend on the

items required to treat

the individual's medical problems.

We will monitor progress on a monthly basis from blood tests and signs and

symptoms and on a

three monthly basis with scans. Monitoring will be done in co-operation with

your local doctor.

One Week of Treatment at The Hope Clinic, Instruction and Collection of

Equipment:

For those patients who cannot afford the time and/or expense of the three

weeks of treatment this

is an excellent option.

We will monitor progress on a monthly basis from blood tests and signs and

symptoms and on a

three monthly basis with scans. Monitoring will be done in co-operation with

your local doctor.

Three Weeks of Treatment at The Hope Clinic, Instruction and Collection of

Equipment:

This the ideal period for our eight different therapies to take effect and

prepare you for home

therapy.

We will monitor progress on a monthly basis from blood tests and signs and

symptoms and on a

three monthly basis with scans. Monitoring will be done in co-operation with

your local doctor.

Telephone Noel on 0412 994 001 to discuss these options and a

starting time.

Dr Sam Queen: Pathology analysis through ARL with a 105 page report:

We are offering an optional new approach to evaluating the patients' body

chemistry and detoxification.

Optional pathology tests evaluate 81 different chemistries in the body and

these results are

passed through a computer program producing a 100 page report.

We are then able to advise you on how to correct the imbalances within you

body and build a

stronger defence against your medical problems.

The cost of the tests are approximately $430 payable to the pathology

laboratory, and a $150 fee to produce the report from software developed by

Dr Sam Queen.

The body deals with toxins in a very ordered fashion:

* Protective barriers and secretions (skin, mucus, tears, saliva)

* Immunological (inflammation, immunoglobulin response)

* Biotransformation (activation of cytochrome P450 enzyme detoxification

systems)

* Raising blood lipids (HDL, LDL and VLDL cholesterol and

tryglycerides.)24,25

By doing a comprehensive blood chemistry, based on the principles of Free

Radical

Therapy,26 we can gain a fairly accurate idea of which toxin or combination

of toxins we

are dealing with, where the toxin is located, how much is there and how it

is being

transported, and thereby gain some idea of how best to neutralize the toxins

and get them

out.

The protocol we use to help the patient get rid of mercury is a multi-step

process. The

first step involves changing the diet to enhance the body's ability to

handle contaminant

materials. The next step adds specific supplementation and chelation

therapy. We then do

a comprehensive survey of the mouth to determine the best order for removal

of

amalgams and the most compatible type of dental material with which to

replace them.

Only then do we proceed with the removal of amalgam fillings.

Upon examining Nervanne's blood results the following findings were of

particular

interest: her total serum cholesterol was very low at 150 mg/dl with

HDL-cholesterol at

48 mg/dl; and her total protein and albumin levels were low, the globulin

was high

normal.

Nervanne's total cholesterol, HDL-cholesterol and total protein levels had

never before

been this low. So I asked her what sort of dietary regimen she had been

following.

Nervanne had not eaten eggs, red meat or dairy products (except skim milk or

soy milk

on her cereal) for several years prior to her devastating decline in health.

She had reduced

her diet to salads, pasta, fruits, an occasional serving of skinless chicken

and frequent

canned tuna due to convenience and her desire to increase her omega-3

intake. She

regularly consumed " cholesterol-free " crackers with margarine and " lite "

cheese as a

snack. She also consumed many other sources of trans fatty acids--margarine,

pastries,

breads, cereals and chocolate.

Did Nervanne's health fail as a result of her new eating habits, or was it

mere coincidence

that her recent health decline followed the adoption of an extremely

low-fat, lowcholesterol,

low-animal-protein diet? I believe it was the latter and the scientific

literature

confirms my beliefs.

Nervanne's reduction in cholesterol and total serum protein had made her

vulnerable to

bacterial and viral infection by promoting T-cell suppression. This is

especially so in the

presence of mercury, which has been shown to reduce resistance to viruses,

cancer and

autoimmune disease.27,28 Low levels of cholesterol also make T-cell

proliferation more

difficult,29,30,31,32 and the excretion of mercury nearly impossible.

The onset of emotional depression and irritability is frequently reported in

people who

suddenly lower their cholesterol levels. These symptoms have occurred in all

of the

longer-term studies on cholesterol lowering, but rarely do physicians link

their patients'

depressive symptoms with the sudden change in diet or cholesterol level.

Neurotoxins are transported throughout the body attached to protein

components of

lipoproteins, and therefore require cholesterol for their transport and

elimination. These

neurotoxins also have a strong affinity for lipoidal tissue of the nervous

system and brain.

A rise in cholesterol levels and triglycerides in response to neurotoxins

protects by

preventing permanent attachment of the neurotoxin to the nerve and brain

cells.

Symptoms of neurotoxicity are most likely to occur when the cholesterol is

lowered

suddenly or when the affected patient goes on a low-fat, low-cholesterol,

low-protein

diet.

In a human trial, a high-protein, low-carbohydrate diet was compared to a

low-protein,

high-carbohydrate diet. The researchers found greater clearance of toxins

with the highprotein,

low-carbohydrate diet and diminished clearance when the ratio was

reversed.33,34

To utilise the protein correctly, the fat on the " lamb " needs to be eaten.

The use of

additional butter or lard in cooking is of paramount importance. By having

adequate fat,

bile production is stimulated, absorption of minerals increased and the

excretion of

mercury facilitated as long as constipation is avoided.

In my practice, I have found that people who are sturdy in structure recover

more quickly

and have less reactivity during their treatment, compared with people who

are extremely

thin or who lose the most weight or undergo ill-advised fasting procedures

concurrently

while having been exposed to toxins such as mercury.35 This observation is

supported by

recent studies published in the Journal of Obesity.36

A correct cholesterol response is fundamental to move mercury and other

neurotoxins to

sites where they can be excreted. A Danish study of 50,318 users of statin

(cholesterol lowering)

drugs revealed a higher risk of peripheral neuropathy related to the

percentage

of drop in total cholesterol. In other words, lowering cholesterol increases

risk of

reactivity to nerve toxins37 resulting in pain, paraesthesia, numbness and

demyelinating

effects. Six additional studies since 1994 have indicated the same rise in

poly peripheral

neuropathy symptoms for users of statin drugs,38,39,40,41,42,43 supporting

our clinical

findings that low cholesterol levels in the presence of a potent neurotoxin

such as

mercury found in amalgam fillings or any other source, is a recipe for

disaster.

Nervanne's history was characteristic of this pattern.

Case History: Therapy:

Our treatment for Nervanne involved a radical change in her diet followed by

the careful

removal of her amalgam fillings (as well as her root-filled teeth). Proper

diet is

fundamental to clearing toxins, as well as to regaining the best of health.

We advised

Nervanne to eliminate tuna and other seafood's from her diet, but to

incorporate a variety

of meats, eggs and whole milk dairy products. The only seafood allowed is

cod liver oil

to provide vitamins A and D.

Protein deprivation has been shown to decrease the liver content of several

of the

cytochrome P450 enzymes, the enzyme system the body calls upon to remove

toxins.44

Mercury also blocks the P450 system.45 Trans fats also interfere with the

P450

detoxification enzyme system, according to research carried out by Dr.

Enig, so

these must also be eliminated from the diet.46

The proteins in the diet must be animal proteins, providing a complete

spectrum of amino

acids. A study of Asian vegetarians with incomplete amino acid intake showed

reduced

clearing of xenobiotics.47 Low levels of hydrochloric acid have an adverse

impact on the

availability of dietary amino acids, even in a higher protein diet, so

stimulating the

pancreas using lacto-fermented foods is crucial. Our protocol makes the use

of cultured

dairy products rich in whey protein. Not only will whey provide the complete

protein

needed for metabolization of xenobiotics and mercury, it has also been shown

to increase

glutathione content in the liver.48,49 We recommend sheep's milk yoghurt,

rich in lauric

acid, whey and glutathione.

By April of 2002, Nervanne's migraines had completely ceased and her

gastrointestinal

symptoms had abated. For the first time in many years, she can string a

sentence together

without stuttering. Her inability to cope, internal irritability and

feelings of helplessness

had resolved and she was now able care for her family and support her

husband's

efforts. The children's behaviours were also improving and the parents were

ready to

commence a program for the child with autism.

REFERENCES

1. Queen HL. Chronic Mercury Toxicity: New Hope Against An Endemic Disease,

Queen and Company Health Communications, Inc., Colorado Springs, Colorado,

1998.

2. Renzoni A, Zino F, Franchi E. Mercury Levels Along the Food Chain and

Risk

for Exposed Populations. Environmental Research, 1998;77(2):68-72.

3. Drexler H, Schaller KH. The Mercury Concentration in Breast Milk

Resulting

from Amalgam Fillings and Dietary Habits. Environmental Research,

1998;77(2):124-129.

4. Arenholt-Bindslev D, Larsen, AH. Mercury Levels and Discharge in Waste

Water

from Dental Clinics. Water Air Soil Pollution, 1996;86(1-4):93-9.

5. Leistevuo J, Leistevuo T, Helenius H, Pyy L, Osterblad M, Huovinen P,

Tenovuo

J. Dental amalgam fillings and the amount of organic mercury in human

saliva.

Caries Res May-June 2001;35(3):163-6.

6. Geier MR, Geier DA 2003, Thimerosal in Childhood Vaccines,

Neurodevelopment Disorders, and Heart Disease in the United States. Journal

of

American Physicians and Surgeons, 2003;8(1):6-11.

7. Renzoni, op cit.

8. Heintze U, son S, Derand T, Birkhed D. Methylation of Mercury from

Dental Amalgam and Mercuric Chloride by Oral Streptococci in vitro. Scand.

J.

Dental Research 1983;91(2) 150-152.

9. Harda M. Minamata Disease: Methylmercury Poisoning in Japan Caused by

Environmental Pollution. Crit Rev Toxicol 1995;25(1):1-24.

10. Fukuda Y, Ushijima K, Kitano T, Sakamoto M, Futatsuka M. An Analysis of

Subjective Complaints in a Population Living in a Methylmercury-Polluted

Area.

Environ Res 1999;81(2):100-107.

11. Renzon1, op cit.

12. Vimy MJ, Lorscheider, FL. Intra-Oral Air Mercury Released from Dental

Amalgam. J Den Res 1985;64:1069-71.

13. Vimy MJ and others. Maternal-fetal Distribution of Mercury203 Released

from

Dental Amalgam Fillings. J Am Physiol 1990, R939-45.

14. Vimy MJ, Lorscheider FL. Dental Amalgam Mercury Daily Dose Estimated

from

Intra-oral Vapor Measurements: a Predictor of Mercury Accumulation in Human

Tissues. J Trace Elem Exp Med 1990;3: 111-23.

15. Drasch G, Roider G. Zahnamalgam und Schwanger-schaft. Geburtsh. und

Frauenheilk, 1995;55:M63-M65.

16. Drexler, op cit.

17. Drexler, op cit

18. Mahafey KR, Rice GE. Environmental Protection Agency Office of Air

Quality

Planning and Standards. Mercury Study Report to Congress. Govt Reports

Announcements and Index (GRA and I), Issue 09,1998. Also Dec, 1999.

www.epa.gov/ttnuatw1/112nmerc/mercury.html.

19. World Health Organization, Environmental Health Criteria 118: Inorganic

Mercury, Geneva, 1991.

20. Geier, op cit.

21. Geier, op cit.

22. Salonen JT and others. Circulation 1995;91:645-55.

23. Salonen JT and others. Circulation October 15, 1995;(Suppl)

92(8):abstract 1040.

24. Queen, HL, Cholesterol-Lowering Drugs Should Carry A Warning: The

Mercury

Connection. Heart Talk 7(2): 9-15, November 1988

25. Queen HL, Health Realities Journal, Number 1,Volume 19, 2003.

26. www.healthrealities.org

27. RB. The carcinogenicity of metals in humans. Cancer Causes &

Control

May 1997;8(3): 371-85.

28. Whitekus MJ and others. Protection Against CD95-Mediated Apoptosis By

Inorganic Mercury In Jurkat T Cells. J Immunol June 15, 1999;162(12):

7162-70.

29. Hui DY, Harmony AK. Biochem J, 1980;192:91.

30. M. Science News, November 1988, p.348.

31. Meydani M. Dietary effects on detoxification processes. In: Hathcock JN,

ed.

Nutritional Toxicology Vol. 2. San Diego, CA: Academic Press; 1987;1-40.

32. Brodie MJ, Boobis AR, Toverud EL and others. Drug metabolism in white

vegetarians. Br J Clin Pharmacol 1980;9:523-525.

33. Kappas A, KE, Conney AH, Alvares AP. Influence of dietary

protein

and carbohydrate on antipyrine and theophylline metabolism in man. Clin

Pharmacol Ther 1976;20:643-653.

34. KE, Kappas A. Dietary regulation of cytochrome P450. Annu Rev

Nutr

1991;11:141-167.

35. s J, Juhaeri M, Cai J. Am J Epidemiol May 15,

2001;153(10):946-953.

36. DB and others. Internat J Obesity & Related Metabol Disorders

March

2002;26(3):410-416.

37. Gaist D and others. Statins and risk of polyneuropathy. Neurol May 1,

2002;58:1333-1337.

38. s MB. Ann Intern Med 1994;120:970.

39. Ahmed S. Lovastatin and Peripheral Neuropathy. Am Heart J 1995;130:1321.

40. Phan T and others. Peripheral Neuropathy Associated with Simvastatin. J

Neurol

Neurosurg Psy 1995;58:625-28.

41. Ziajka PE. South Med J 1998;91:667-68.

42. Jeppesen U and others. Eur J Clin Pharmacol 1999;54:835-38.

43. Gaist D and others. Eur J Clin Pharmacol 2001;56:931-33.

44. Meydani M. Dietary effects on detoxification processes. In: Hathcock JN,

ed.

Nutritional Toxicology Vol. 2. San Diego, CA: Academic Press; 1987;1-40.

45. , op cit.

46. Enig MG. Modification of Membrane Lipid Composition and Mixed-Function

Oxidases in Mouse Liver Microsomes by Dietary Trans Fatty Acids. Doctoral

Thesis, University of land, 1984.

47. Brodie MJ, Boobis AR, Toverud EL and others. Drug metabolism in white

vegetarians. Br J Clin Pharmacol 1980;9:523-525.

48. Bounous G, Gervais F, Amer V and others. The influence of dietary whey

protein

on tissue glutathione and the diseases of aging. Clin Invest Med

1989;12:343-349.

49. McIntosh GH, Regester GO, Le Leu RK and others. Dairy proteins protect

against

dimethylhydrazine-induced intestinal cancers in rats. J Nutr

1995;125:809-816.

167 Street Melbourne Australia

P O Box 137 Parkville 3052 Australia

Telephone 03 9639 6090 International 613 9639 6090

Mobile 0412 994 001 International 61 412 994 001

Fax 03 9639 4006 International 613 9639 4006

Web www.smile.org.au

Sapere aude: 'Dare to be wise'

The information transmitted in this document is intended only for the

recipient(s) to which it is addressed and may contain confidential and

privileged material.

Any review, retransmission, dissemination or other use of, or taking any

action in reliance upon, this information by persons or entities other than

the intended recipient is prohibited.

If you receive this in error, please contact the sender and then delete. We

have taken precautions to minimise the risk of transmitting software

viruses, but we advise you to carry out your own virus checks on any

attachment to this message. We cannot accept liability for any loss or

damage caused by software viruses.